ID   LanthaScreen ATF2 (19-106) A549
AC   CVCL_ZI99
DR   cancercelllines; CVCL_ZI99
DR   Wikidata; Q98126848
WW   Provider; Thermo Fisher; K1679B; https://www.thermofisher.com/order/catalog/product/K1679B
CC   Population: Caucasian.
CC   Characteristics: Transfected with an EmGFP-ATF2(19-106) construct whose expression is under the control of a CMV promoter.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; GLAD6; Emerald (Note=EmGFP, green fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:784; ATF2 (Note=With p.Met1_Asn18del and p.Met107_Ser505del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; B.cereus Bsr.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//